CAXTON CORP Diversified Active

CIK: 0001388551 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value ($000): $17,552 (100.0% shares, 0.0% debt)

Holdings (11)

XERS XERIS BIOPHARMA HOLDINGS INC 64.4%
Value ($000) $11,300 Shares 5,113,348 Est. Cost $2.16 Unrealized +19.8%
RZLT REZOLUTE INC 19.2%
Value ($000) $3,363 Shares 1,318,967 Est. Cost $9.52 Unrealized -85.1%
SPY SPDR S&P 500 ETF TR 5.5%
Value ($000) $971 Shares 1,856 Est. Cost $488.96 Unrealized —
BRK/B BERKSHIRE HATHAWAY INC DEL 2.4%
Value ($000) $428 Shares 1,019 Est. Cost $350.99 Unrealized +12.1%
KYTX KYVERNA THERAPEUTICS INC 2.2%
Value ($000) $394 Shares 15,846 Est. Cost $27.84 Unrealized 0.0%
— MOLECULAR TEMPLATES INC 1.7%
Value ($000) $307 Shares 136,866 Est. Cost $6.32 Unrealized —
— MIND MEDICINE MINDMED INC 1.6%
Value ($000) $273 Shares 29,065 Est. Cost $9.40 Unrealized —
ABVX ABIVAX SA 1.3%
Value ($000) $226 Shares 15,808 Est. Cost $10.70 Unrealized —
LXEO LEXEO THERAPEUTICS INC 0.9%
Value ($000) $162 Shares 10,319 Est. Cost $12.42 Unrealized +25.9%
CMPX COMPASS THERAPEUTICS INC 0.5%
Value ($000) $86 Shares 43,465 Est. Cost $3.23 Unrealized -46.5%
— ADICET BIO INC 0.2%
Value ($000) $41 Shares 17,488 Est. Cost $2.35 Unrealized —